Table 1.

Univariate and multivariate Cox analysis of prognostic factors for DLBCL (PFS).

Prognostic factors	Adverse factors	One-way ANOVA		Multivariate Cox analysis
		eta	p-value	HR (95% CI)	p-value
Sexual distinction	Male	0.02	0.878
Age	≥ 60	0.014	0.912
Position	Extranodal	0.133	0.3
Origin	Non-GCB	0.014	0.913
MYC	≥ 40%	0.035	0.787
BCL-2	≥ 50%	0.206	0.106	1.238 (0.569–2.693)	0.59
BCL-6	≥ 30%	0.146	0.252
P53	≥ 50%	0.009	0.942
FMYC	+	0.052	0.683
FBCL6	+	0.145	0.256
Ki-67	≥ 80%	0.015	0.904
LDH (IU/L)	≥ 250	0.353	0.004	1.806 (0.869–3.751)	0.113
Seralbumin (g/L)	≥ 40	0.024	0.855
AST	≥ 50	0.043	0.739
β2-MG	≥ 3	0.138	0.279
Stage	III, IV	0.278	0.027	2.534 (0.987–6.507)	0.053
B symptom	Yes	0.117	0.362
Extranodal number	≥ 2	0.159	0.214
Bulky	Yes	0.004	0.974
ECOG	≥ 2	0.235	0.063	0.823 (0.404–1.676)	0.592
R 2	No	0.015	0.910
POD12	Yes	0.435	< 0.001	0.235 (0.106–0.524)	< 0.001
NLR	≥ 1.73	0.194	0.127	0.813 (0.309–2.138)	0.675
PLR	≥ 306.494	0.062	0.629
SII	≥ 304.2	0.182	0.153	0.675 (0.275–1.657)	0.391
LMR	≥ 4.867	0.008	0.948